<unk>  is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in people with non-ST elevation acute coronary syndrome.
Tirofiban
Tafamidis
Clopidogrel
Ticagrelor
Ticlopidine
Eptifibatide
Clofibride
Cetrorelix